Cargando…
Discovery of Novel Pyridazine-Based Cyclooxygenase-2 Inhibitors with a Promising Gastric Safety Profile
Cyclooxygenase-2 (COX-2) is implicated in the development of chronic inflammatory diseases. Recently, pyridazine derivatives have emerged as a novel prototype to develop COX-2 inhibitors. Accordingly, some pyridazine-based COX-2 inhibitors are reported herein. The reaction of aldehyde 3 and differen...
Autores principales: | Khan, Abida, Diwan, Anupama, Thabet, Hamdy Kh., Imran, Mohd, Bakht, Md. Afroz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249006/ https://www.ncbi.nlm.nih.gov/pubmed/32344801 http://dx.doi.org/10.3390/molecules25092002 |
Ejemplares similares
-
The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature
por: Imran, Mohd, et al.
Publicado: (2022) -
Comparative Proteomics and Genome-Wide Druggability Analyses Prioritized Promising Therapeutic Targets against Drug-Resistant Leishmania tropica
por: Aiman, Sara, et al.
Publicado: (2023) -
The pyridazine heterocycle in molecular recognition and drug discovery
por: Meanwell, Nicholas A.
Publicado: (2023) -
An Improved Synthesis of Key Intermediate to the Formation of Selected Indolin-2-Ones Derivatives Incorporating Ultrasound and Deep Eutectic Solvent (DES) Blend of Techniques, for Some Biological Activities and Molecular Docking Studies †
por: Imran, Mohd, et al.
Publicado: (2020) -
Cyclooxygenase-2 inhibitors: promise or peril?
por: Mengle-Gaw, Laurel J, et al.
Publicado: (2002)